Sérgio Leal

Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study

Won Ki Lee, Tomohiro Iida, Yuichiro Ogura et al. · JAMA Ophthalmology · 2018 · 253 citations · Full text

Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial

Paolo Lanzetta, Jean‐François Korobelnik, Jeffrey S. Heier et al. · The Lancet · 2024 · 179 citations

Translational Medicine, Ocular Disease, Ophthalmology +5

Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy: Two-Year Results of the Aflibercept in Polypoidal Choroidal Vasculopathy Study

Tien Yin Wong, Yuichiro Ogura, Won Ki Lee et al. · American Journal of Ophthalmology · 2019 · 104 citations

Ophthalmology, Two-year Results, Intravitreal Aflibercept +2

PHOTODYNAMIC THERAPY WITH VERTEPORFIN IN POLYPOIDAL CHOROIDAL VASCULOPATHY

Sérgio Leal, Rufino Silva, João Figueira et al. · Retina · 2010 · 56 citations

Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention—MACUSTAR

Jan Henrik Terheyden, Frank G. Holz, Steffen Schmitz-Valckenberg et al. · Trials · 2020 · 35 citations · Full text